Women’s Visionary Council Becomes Nonprofit Fiscal Sponsor for the Sage Institute

The Women’s Visionary Council (WVC) is pleased to announce that we are now the nonprofit fiscal sponsor for Sage Institute in Oakland, CA. Sage Institute is a sliding-scale clinic offering psychotherapy and psychedelic-assisted therapy (as it becomes legal) to under-served communities in the San Francisco Bay Area. In addition to therapy services, Sage Institute is a training clinic that provides rigorous educational programs for clinicians who reflect the diverse identities of the communities they serve. 

The WVC accepts tax-deductible donations to support Sage Institute while the clinic applies for nonprofit status. Sage Institute is funded solely by donations and presently staffed by volunteers. It needs community support to help make therapy, psychedelic healing, and training more accessible to people who have not had access to affordable treatment. You can support Sage Institute by making a tax-deductible donation below. You can also join WVC members and other patrons of Sage Institute by attending their upcoming fundraising and launch event at The Haven at 3007 Telegraph Ave. in Oakland CA on Friday, October 25, 2019, starting at 7pm. We’ll see you there!

image.jpg

SUPPORT THE WVC

Since 2008, the Women’s Visionary Council (WVC) has provided funding, gatherings, and support for women healers, researchers, activists, and artists who work with non-ordinary states of consciousness. The WVC is a non-profit 5013C nonprofit organization sustained by donors and members. All donations to the WVC are tax-deductible. A donation of $75 makes you a member of the WVC eligible for discounts on WVC events, the WVC newsletter, and the ability to nominate people and organizations for WVC grants. Donations of any size can be made via PayPal, cash donations at WVC events, or by mailing a check to P.O. Box 5305 Berkeley, CA 94705.

IMG_1241.jpg

HISTORY

The WVC was founded in 2008 by female researchers and activists who saw that women were excluded from critical public discussions about emerging therapies for post-traumatic stress disorder, end of life anxiety, depression, addiction, and other mental health conditions.